4th Quarter - Report

BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC for BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC

Period 4th Quarter 2018 Filed Jan 18, 2019 Signed by Edward Buckley

Official filing
Firm
BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
Client
BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Alcohol and Drug Abuse ALC

Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Opioid Crisis

LobbyistCovered position, as disclosed
EDWARD BUCKLEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.